Answers are grounded in this paper and cite their sources.
BACKGROUND: To explain observed differences during SPF determination using either an in vivo or in vitro method, we hypothesized on the presence of ingredients having anti-inflammatory properties. METHODOLOGY/PRINCIPAL FINDINGS: To research our hypothesis, we studied the 21 UV filters both available on the market and authorized by European regulations and subjected these filters to the phorbol-myristate-acetate test using mice. We then catalogued the 13 filters demonstrating a significant anti-inflammatory effect with edema inhibition percentages of more than 70%. The filters are: diethylhexyl butamido triazone (92%), benzophenone-5 and titanium dioxide (90%), benzophenone-3 (83%), octocrylène and isoamyl p-methoxycinnamate (82%), PEG-25 PABA and homosalate (80%), octyl triazone and phenylbenzimidazole sulfonic acid (78%), octyl dimethyl PABA (75%), bis-ethylhexyloxyphenol methoxyphenyl triazine and diethylamino hydroxybenzoyl hexylbenzoate (70%). These filters were tested at various concentrations, including their maximum authorized dose. We detected a dose-response relationship. CONCLUSIONS/SIGNIFICANCE: The anti-inflammatory effect of a sunscreen ingredient may affect the in vivo SPF value.
No takes yet. Share an insight, caveat, or question.
Couteau et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: